Variant report
Variant | nsv523101 |
---|---|
Chromosome Location | chr11:57843506-57871866 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:47)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:47 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr11:57843315-57843588 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr11:57843233-57843677 | IMR90 | lung: | n/a | n/a |
3 | CEBPB | chr11:57843424-57843525 | HepG2 | liver: | n/a | n/a |
4 | CEBPB | chr11:57843315-57843635 | HepG2 | liver: | n/a | n/a |
5 | CTCF | chr11:57870800-57870950 | K562 | blood: | n/a | n/a |
6 | CTCF | chr11:57870660-57870810 | K562 | blood: | n/a | n/a |
7 | E2F4 | chr11:57843257-57843601 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | EP300 | chr11:57861555-57861605 | GM12878 | blood: | n/a | n/a |
9 | EP300 | chr11:57864652-57865487 | T-47D | breast: | n/a | n/a |
10 | EP300 | chr11:57843477-57843515 | HepG2 | liver: | n/a | n/a |
11 | EP300 | chr11:57864864-57865325 | T-47D | breast: | n/a | n/a |
12 | FAM48A | chr11:57843863-57843941 | GM12878 | blood: | n/a | n/a |
13 | FAM48A | chr11:57867041-57867211 | GM12878 | blood: | n/a | n/a |
14 | FOS | chr11:57856486-57856655 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | FOS | chr11:57856618-57856621 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | FOS | chr11:57843156-57843667 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | FOS | chr11:57843194-57843694 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | FOS | chr11:57856469-57856661 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | FOS | chr11:57843218-57843630 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | FOS | chr11:57843233-57843657 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | FOSL2 | chr11:57843238-57843559 | HepG2 | liver: | n/a | n/a |
22 | FOXA1 | chr11:57864795-57865379 | T-47D | breast: | n/a | n/a |
23 | FOXA1 | chr11:57864621-57865459 | T-47D | breast: | n/a | n/a |
24 | GATA3 | chr11:57864677-57865551 | T-47D | breast: | n/a | n/a |
25 | GATA3 | chr11:57864797-57865539 | T-47D | breast: | n/a | n/a |
26 | JUN | chr11:57843281-57843607 | HepG2 | liver: | n/a | n/a |
27 | JUND | chr11:57864656-57865505 | T-47D | breast: | n/a | n/a |
28 | JUND | chr11:57843331-57843517 | HepG2 | liver: | n/a | chr11:57843421-57843432 |
29 | JUND | chr11:57843245-57843621 | HepG2 | liver: | n/a | chr11:57843421-57843432 |
30 | MAFF | chr11:57847219-57847503 | HepG2 | liver: | n/a | chr11:57847365-57847383 |
31 | MAFK | chr11:57847212-57847504 | HepG2 | liver: | n/a | chr11:57847367-57847382 |
32 | MAFK | chr11:57863554-57863789 | HepG2 | liver: | n/a | chr11:57863670-57863681 chr11:57863670-57863681 chr11:57863671-57863682 |
33 | MAFK | chr11:57847257-57847457 | IMR90 | lung: | n/a | chr11:57847367-57847382 |
34 | MAFK | chr11:57847222-57847509 | HepG2 | liver: | n/a | chr11:57847367-57847382 |
35 | MXI1 | chr11:57847113-57847198 | GM12878 | blood: | n/a | n/a |
36 | MYC | chr11:57843346-57843660 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | MYC | chr11:57843317-57843600 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | POLR2A | chr11:57843396-57843566 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | POLR2A | chr11:57843357-57843546 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | RAD21 | chr11:57843324-57843626 | IMR90 | lung: | n/a | n/a |
41 | RCOR1 | chr11:57842852-57844109 | IMR90 | lung: | n/a | n/a |
42 | SETDB1 | chr11:57869952-57870323 | U2OS | brain: | n/a | n/a |
43 | STAT3 | chr11:57843200-57843610 | MCF10A-Er-Src | breast: | n/a | n/a |
44 | STAT3 | chr11:57843201-57843604 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | STAT3 | chr11:57853418-57853448 | MCF10A-Er-Src | breast: | n/a | n/a |
46 | STAT3 | chr11:57843229-57843658 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | STAT3 | chr11:57853983-57854119 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000254853 | TF binding region |
OR9L1P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2513725 | chr11:57843506-57843507 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs200216340 | chr11:57843507-57843508 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs553646990 | chr11:57843527-57843528 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs148654838 | chr11:57843602-57843603 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs2513724 | chr11:57843609-57843610 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs367834964 | chr11:57843613-57843614 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs371367200 | chr11:57843616-57843617 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs531286198 | chr11:57843650-57843651 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs572082523 | chr11:57843653-57843654 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs142237166 | chr11:57843682-57843683 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs151215628 | chr11:57843688-57843689 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs73476501 | chr11:57843706-57843707 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs189022618 | chr11:57843722-57843723 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs576506427 | chr11:57843764-57843765 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs117091508 | chr11:57843819-57843820 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs542255267 | chr11:57843883-57843884 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs536194562 | chr11:57843919-57843920 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs554746474 | chr11:57843954-57843955 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs201923160 | chr11:57844001-57844002 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs181373794 | chr11:57844021-57844022 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs544701718 | chr11:57844034-57844035 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs140469352 | chr11:57844036-57844037 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs578147825 | chr11:57844048-57844049 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs185699511 | chr11:57844058-57844059 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs189623849 | chr11:57844104-57844105 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs367736900 | chr11:57844148-57844149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371974642 | chr11:57844173-57844174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs180898907 | chr11:57844207-57844208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542982019 | chr11:57844219-57844220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185899910 | chr11:57844234-57844235 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12802761 | chr11:57844258-57844259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572731431 | chr11:57844260-57844261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375083951 | chr11:57844357-57844358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs6591455 | chr11:57844371-57844372 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs570959925 | chr11:57844394-57844395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs549152003 | chr11:57844416-57844417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564356634 | chr11:57844493-57844494 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs532084601 | chr11:57844517-57844518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs547359283 | chr11:57844525-57844526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374093820 | chr11:57844563-57844564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs533310750 | chr11:57844566-57844567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536524390 | chr11:57844577-57844578 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554600505 | chr11:57844646-57844647 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs145644840 | chr11:57844670-57844671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs541942635 | chr11:57844679-57844680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs563091127 | chr11:57844693-57844694 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558796150 | chr11:57844715-57844716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs578138253 | chr11:57844749-57844750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs565732608 | chr11:57844832-57844833 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538805762 | chr11:57844836-57844837 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495309 | CNVD |
Autism | 20808228 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:57826400-57845200 | Weak transcription | Pancreas | Pancrea |
2 | chr11:57840800-57847200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr11:57842800-57844000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr11:57843000-57843600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr11:57843000-57843800 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr11:57843000-57844000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
7 | chr11:57843000-57844000 | Enhancers | HepG2 | liver |
8 | chr11:57843000-57844000 | Enhancers | NHEK | skin |
9 | chr11:57843000-57844200 | Enhancers | HSMM | muscle |
10 | chr11:57843200-57844000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr11:57843400-57843800 | Enhancers | HSMMtube | muscle |
12 | chr11:57843400-57844000 | Enhancers | HMEC | breast |
13 | chr11:57844000-57846800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
14 | chr11:57844200-57844600 | Weak transcription | HSMM | muscle |
15 | chr11:57844600-57845000 | Enhancers | HSMM | muscle |
16 | chr11:57847200-57847400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |